Study immune response to COVID-19 and improve testing
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old and weigh at least 50 kg
- Live in the Ile-de-France region and be able to travel to the 15th arrondissement of Paris for study visits
- Agree to join the study and provide consent
- Have access to Social Security coverage (except Aide Médicale d'Etat)
- If COVID-positive: test by RT-PCR within the last 72 hours and be symptom-free or have mild symptoms that do not need hospital care
- If COVID-negative: have a recent RT-PCR test that is negative and have no more than 3 health conditions (co-morbidities) listed by HAS
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study collects immune cells from people who recovered from COVID-19 and may use them to boost protection against SARS-CoV-2. It’s for hospitalized patients who already show a certain level of COVID-19 fighting immune response.
This study checks whether different COVID-19 tests (a blood test and swab-based tests) can detect or confirm infection. If you join, you’ll follow the study steps so researchers can compare results and improve testing.
This study looks at how the immune system responds to COVID-19 in healthcare workers and infected patients at Danderyd Hospital. It aims to understand immunity and help guide future care.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.